Equibles does not estimate personal net worth.
Get an email with a short summary when Teva Pharmaceutical Industries Ltd publishes a filing, an earnings call transcript or a press release.
Get TEVA alertsEliyahu Kalif is recorded as CFO at Teva Pharmaceutical Industries Ltd (TEVA). Eliyahu Kalif has spoken on 4 earnings calls across 1 company, most recently for Teva Pharmaceutical Industries Ltd on July 29, 2026. Teva Pharmaceutical Industries Ltd is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Teva Pharmaceutical Industries Ltd includes Richard Francis (CEO and Board Member), Eli Kalif (CFO), Amir Weiss (Chief Accounting Officer) and 7 others.
“I would like to start my review of Q2 26 results with the following key messages. First, we delivered a solid second quarter results, driven once again by the continued strength of our innovative portfolio.”
“I would like to start my review of Q126 results with the following key messages. First, we started the year with a solid first quarter result, driven by continued strength in our innovative portfolio.”
“I will review our 2025 financial results, focusing on our fourth quarter performance, followed by our outlook for 2026. I would like to start with the following key messages that highlight our consistent execution throughout 2025.”
“I would like to start today with the following key messages that demonstrate our consistent execution over the last few quarters, including Q2. First, Q2 came in with a solid performance driven by our fast-growing innovative portfolio despite tough year-over-year comparables of our generic business.”
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
